Anti-LAMB1/ CLM/ LIS5 functional antibody

Anti-LAMB1/ CLM/ LIS5 functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to LAMB1/LAMB1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-SE0300-Ab-1/ GM-Tg-hg-SE0300-Ab-2Anti-Human LAMB1 monoclonal antibodyHuman
GM-Tg-rg-SE0300-Ab-1/ GM-Tg-rg-SE0300-Ab-2Anti-Rat LAMB1 monoclonal antibodyRat
GM-Tg-mg-SE0300-Ab-1/ GM-Tg-mg-SE0300-Ab-2Anti-Mouse LAMB1 monoclonal antibodyMouse
GM-Tg-cynog-SE0300-Ab-1/ GM-Tg-cynog-SE0300-Ab-2Anti-Cynomolgus/ Rhesus macaque LAMB1 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-SE0300-Ab-1/ GM-Tg-felg-SE0300-Ab-2Anti-Feline LAMB1 monoclonal antibodyFeline
GM-Tg-cang-SE0300-Ab-1/ GM-Tg-cang-SE0300-Ab-2Anti-Canine LAMB1 monoclonal antibodyCanine
GM-Tg-bovg-SE0300-Ab-1/ GM-Tg-bovg-SE0300-Ab-2Anti-Bovine LAMB1 monoclonal antibodyBovine
GM-Tg-equg-SE0300-Ab-1/ GM-Tg-equg-SE0300-Ab-2Anti-Equine LAMB1 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-SE0300-Ab-1/ GM-Tg-hg-SE0300-Ab-2; GM-Tg-rg-SE0300-Ab-1/ GM-Tg-rg-SE0300-Ab-2;
GM-Tg-mg-SE0300-Ab-1/ GM-Tg-mg-SE0300-Ab-2; GM-Tg-cynog-SE0300-Ab-1/ GM-Tg-cynog-SE0300-Ab-2;
GM-Tg-felg-SE0300-Ab-1/ GM-Tg-felg-SE0300-Ab-2; GM-Tg-cang-SE0300-Ab-1/ GM-Tg-cang-SE0300-Ab-2;
GM-Tg-bovg-SE0300-Ab-1/ GM-Tg-bovg-SE0300-Ab-2; GM-Tg-equg-SE0300-Ab-1/ GM-Tg-equg-SE0300-Ab-2
Products NameAnti-LAMB1 monoclonal antibody
Formatmab
Target NameLAMB1
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-LAMB1 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-SE0300-Ag-1Recombinant multi-species LAMB1/ CLM/ LIS5 protein


    Target information

    Target IDGM-SE0300
    Target NameLAMB1
    Gene ID3912,16777,298941,702111,475882,101080367,520030,100060360
    Gene Symbol and SynonymsCLM,D130003D08Rik,Lamb-1,LAMB1,Lamb1-1,LIS5
    Uniprot AccessionP07942
    Uniprot Entry NameLAMB1_HUMAN
    Protein Sub-locationSecreted Protein/Potential Cytokines
    Category
    DiseaseN/A
    Gene EnsemblENSG00000091136
    Target ClassificationN/A

    The target: LAMB1, gene name: LAMB1, also named as CLM, LIS5. Laminins, a family of extracellular matrix glycoproteins, are the major noncollagenous constituent of basement membranes. They have been implicated in a wide variety of biological processes including cell adhesion, differentiation, migration, signaling, neurite outgrowth and metastasis. Laminins are composed of 3 non identical chains: laminin alpha, beta and gamma (formerly A, B1, and B2, respectively) and they form a cruciform structure consisting of 3 short arms, each formed by a different chain, and a long arm composed of all 3 chains. Each laminin chain is a multidomain protein encoded by a distinct gene. Several isoforms of each chain have been described. Different alpha, beta and gamma chain isomers combine to give rise to different heterotrimeric laminin isoforms which are designated by Arabic numerals in the order of their discovery, i.e. alpha1beta1gamma1 heterotrimer is laminin 1. The biological functions of the different chains and trimer molecules are largely unknown, but some of the chains have been shown to differ with respect to their tissue distribution, presumably reflecting diverse functions in vivo. This gene encodes the beta chain isoform laminin, beta 1. The beta 1 chain has 7 structurally distinct domains which it shares with other beta chain isomers. The C-terminal helical region containing domains I and II are separated by domain alpha, domains III and V contain several EGF-like repeats, and domains IV and VI have a globular conformation. Laminin, beta 1 is expressed in most tissues that produce basement membranes, and is one of the 3 chains constituting laminin 1, the first laminin isolated from Engelbreth-Holm-Swarm (EHS) tumor. A sequence in the beta 1 chain that is involved in cell attachment, chemotaxis, and binding to the laminin receptor was identified and shown to have the capacity to inhibit metastasis. [provided by RefSeq, Aug 2011].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.